VETOQUINOL TO ACQUIRE RIGHTS FOR PROFENDER® AND DRONTAL® FROM ELANCO ANIMAL HEALTH FOR THE EUROPEAN ECONOMIC AREA AND THE UK
February 12 th , 2020 (Lure, France) - Vetoquinol has agreed terms to acquire the European Economic area and UK rights to Profender® and Drontal® product families from Elanco Animal Health. This acquisition will be financed through a combination of available cash and committed financing from Vetoquinol banking partners for $140 million in an all cash deal subject to customary post-closing adjustments. The deal is expected to close by mid-year 2020.
- Public releases
Vetoquinol has been listed on the Euronext Paris stock market since November 16th.
Composition of the bodies of Corporate Management and Governance
Financial information and key figures: annual, half-year and by sector key figures